Tiopronin Delayed-Release Tablets are the same proven Tiopronin (active ingredient) as Thiola EC® (tiopronin) Delayed-Release Tablets that you may be taking for cystinuria.1 This treatment is complemented by MyCare SolutionsTM, a dedicated specialty pharmacy designed to assist you in managing the availability of this medication. With Tiopronin Delayed-Release Tablets and MyCare Solutions, you can approach your treatment plan with assurance and confidence.
Tiopronin Delayed-Release Tablets are the same proven Tiopronin (active ingredient) as Thiola EC® (tiopronin) Delayed-Release Tablets that you may be taking for cystinuria.1 This treatment is complemented by MyCare SolutionsTM, a dedicated specialty pharmacy designed to assist you in managing the availability of this medication. With Tiopronin Delayed-Release Tablets and MyCare Solutions, you can approach your treatment plan with assurance and confidence.
Identical to Thiola EC (tiopronin) Delayed-Release Tablets.
Managing your specialty medication with personalized care and support – Available only through MyCare Solutions.
Download and print the MyCare Solutions enrollment form, share it with your doctor and discuss why you think Tiopronin Delayed-Release Tablets may be suited for your needs.
*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility or terms and conditions, please contact the MyCare Solutions team at 1-844-849-3636.
Reference
1. Tiopronin Delayed-Release Tablets [package insert]. San Antonio, TX: BioComp Pharma, Inc.
What are Tiopronin Delayed-Release Tablets?
Tiopronin Delayed-Release Tablets are a prescription medication. It is used in combination with high fluid intake, alkali (low acid), and dietary changes to help prevent the formation of one type (cystine) of kidney stones in certain adult and pediatric patients that weigh at least 44 pounds (20 kg) and who do not respond to these measures alone.
Who should not take Tiopronin Delayed-Release Tablets?
Tiopronin Delayed-Release Tablets should not be taken if you:
What should I tell my doctor before taking Tiopronin Delayed-Release Tablets?
Tiopronin Delayed-Release Tablets may not be right for you. Before taking Tiopronin Delayed-Release Tablets, tell your doctor about:
What should I avoid while taking Tiopronin Delayed-Release Tablets?
You should avoid drinking alcohol 2 hours before and 3 hours after taking Tiopronin Delayed-Release Tablets.
What are possible side effects of Tiopronin Delayed-Release Tablets?
Serious Side Effects: Tiopronin Delayed-Release Tablets can cause proteinuria (high amounts of protein in urine), including serious kidney problems, and hypersensitivity reactions (including fever, rash, joint pain and enlarged or swollen lymph nodes).
Most Common Side Effects: Nausea, diarrhea or soft stools, sores in the mouth, rash, fatigue, fever, muscle or joint pain, high amounts of protein in urine, vomiting.
These are not all the possible side effects of Tiopronin Delayed-Release Tablets. Call your doctor for medical advice about side effects.
You may report negative side effects to BioComp Pharma, Inc. at 1-866-762-2365, or to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information including additional Important Safety Information.
Proudly manufactured in the USA
This material is intended to provide basic information and is not medical advice. All medical advice, diagnosis, and treatment should be obtained from your physician. The product information provided in this site is intended for residents of the United States.
Copyright © 2025 BioComp Pharma, Inc. All rights reserved.
Proudly manufactured in the USA
This material is intended to provide basic information and is not medical advice. All medical advice, diagnosis, and treatment should be obtained from your physician. The product information provided in this site is intended for residents of the United States.
Copyright © 2025 BioComp Pharma, Inc. All rights reserved.